The big news circulating this week was of Atea Pharmaceuticals’ (NASDAQ: AVIR) COVID-19 antiviral clinical trial failure, which instantly plummeted the stock...
CytoDyn Inc. (OTCMKTS:CYDY) on a conference call yesterday revealed that approximately 250 patients have been recruited in their CD12 severe to cri...
Abbott Laboratories (NYSE:ABT) and Mylan Inc declared that they would move further with their $5.3 B agreement in which Mylan will purchase...